Piyathilake Chandrika J, Bell Walter C, Oelschlager Denise K, Heimburger Douglas C, Grizzle William E
Division of Nutritional Biochemistry and Molecular Biology, University of Alabama at Birmingham, University Station, Birmingham, Alabama 35294, USA.
Head Neck. 2002 Sep;24(9):859-67. doi: 10.1002/hed.10135.
Despite the importance of reactive oxygen species (ROS) in the development of smoking-related cancers, little is known about the pattern of expression of ROS scavengers in these cancers.
In this present study, we examined the expression of manganese superoxide dismutase (Mn-SOD) and copper/zinc superoxide dismutase (Cu-Zn-SOD), which are essential enzymes that eliminate ROS, in squamous cell cancers (SCCs) of the lung (n = 12), larynx (n = 13), and oral cavity (n = 20).
SCCs of larynx and oral cavity showed significantly enhanced immuhistochemical expression of Mn-SOD compared with the matched uninvolved epithelium. The higher expression of Mn-SOD was shown to be late and early events in the process of SCC development in the larynx and the oral cavity, respectively. The expression of Mn-SOD in SCCs of the lung was significantly lower compared with luminal cells of the uninvolved epithelium but not compared with basal cells or an average expression of SOD in basal and luminal cells. The expression of both Mn-SOD and cytoplasmic or nuclear Cu-Zn-SOD in bronchial epithelium adjacent to invasive cancer was significantly lower compared with its expression in the uninvolved bronchial epithelium away from cancer. This resulted in a significant difference in SOD expression between cancer and uninvolved bronchial epithelium away from cancer but not between cancer and uninvolved epithelium adjacent to cancer.
There are significant differences in the expression of Mn-SOD and Cu-Zn-SOD among SCCs of the lung, larynx, and oral cavity. The results also suggest that variations in distance between cancer and uninvolved tissues evaluated could contribute to conflicting results of SOD expression.
尽管活性氧(ROS)在吸烟相关癌症的发生发展中具有重要作用,但对于这些癌症中ROS清除剂的表达模式却知之甚少。
在本研究中,我们检测了锰超氧化物歧化酶(Mn-SOD)和铜/锌超氧化物歧化酶(Cu-Zn-SOD)的表达,这两种酶是清除ROS的关键酶,检测对象为肺癌(n = 12)、喉癌(n = 13)和口腔癌(n = 20)的鳞状细胞癌(SCC)。
与配对的未受累上皮相比,喉癌和口腔癌的SCC显示出Mn-SOD免疫组化表达显著增强。结果表明,Mn-SOD表达升高分别是喉癌和口腔癌SCC发生过程中的晚期和早期事件。与未受累上皮的管腔细胞相比,肺癌SCC中Mn-SOD的表达显著降低,但与基底细胞相比或与基底细胞和管腔细胞中SOD的平均表达相比则无显著差异。与远离癌症的未受累支气管上皮相比,侵袭性癌旁支气管上皮中Mn-SOD以及细胞质或细胞核Cu-Zn-SOD的表达均显著降低。这导致癌症与远离癌症的未受累支气管上皮之间SOD表达存在显著差异,但癌症与癌旁未受累上皮之间则无显著差异。
肺癌、喉癌和口腔癌的SCC中Mn-SOD和Cu-Zn-SOD的表达存在显著差异。结果还表明,评估的癌症与未受累组织之间距离的变化可能导致SOD表达结果相互矛盾。